Delivery Order SPE2DB25D3202-SPE2DB25FTANY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,462.82 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on July 18, 2025, with an ultimate completion date of July 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order contract valued at $18,016.80 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on August 5, 2025, with an ultimate completion date of August 6, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,107.78 delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials under a firm fixed price contract effective August 18, 2025, with completion scheduled for August 19, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,345.16 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, serves as...
- The Defense Logistics Agency awarded a delivery order valued at $1,664.80 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on August 12, 2025, with completion scheduled for August 13, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves...
- The Defense Logistics Agency awarded a delivery order valued at $1,175.66 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of July 23, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The award represents a single transaction under AmerisourceBergen's broader federal contract portfolio supporting military and veteran healthcare procurement needs....
- The Defense Logistics Agency awarded a $4,685.90 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of M-M-R II vaccine vials. The contract utilizes firm fixed pricing with an ultimate completion date of August 11, 2025, and represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order is issued under...
- The Defense Logistics Agency awarded a $16,922.64 delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on September 4, 2025, with completion scheduled for September 5, 2025. This firm fixed-price contract was competitively awarded without set-aside restrictions and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen, a major pharmaceutical distributor and critical vendor for federal medical procurement, is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials valued at $6,594.16 on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The vaccine vials will be delivered to the contractor's facility...
- The Defense Logistics Agency awarded a delivery order valued at $4,511.07 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of July 23, 2025. This firm fixed price contract, issued on July 22, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where the company serves as a...
- SPE2DB25D3202Indefinite Delivery Contract
- SPE2DB25D3202-SPE2DB25FTANYDelivery Order
The Defense Logistics Agency awarded a $1,484.82 firm fixed price delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on June 2, 2025, with an ultimate completion date of June 3, 2025. The contract, which is a child order under a larger vehicle, was performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, and was awarded without a set-aside designation through open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies vaccines, medications, and medical supplies to support military and veteran healthcare systems. This delivery order falls under AmerisourceBergen Drug Corp's comprehensive Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The parent IDC serves as a global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide, including vaccines, specialty medications, and medical supplies across multiple therapeutic domains. The contractor's ability to fulfill this vaccine order reflects its established role as a primary vendor supporting the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 6/2/25 |